Trial Information
Randomized Trial of Exercise Training in Postmenopausal Patients With Hormone-receptor Positive Breast Cancer Undergoing Treatment With Aromatase Inhibitors
Inclusion Criteria:
- Signed informed consent
- Postmenopausal women with hormone receptor positive breast cancer (as defined by HR
>= ++ and/or PR >= ++) who are treated with aromatase inhibitors
- ECOG performance status <= 2
- all age groups
Exclusion Criteria:
- Pathologic ergometry
- Uncontrolled diabetes mellitus
- Uncontrolled hypertension
- COPD > II
- Active opportunistic infection
- NYHA heart failure III or IV
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Outcome Measure:
Individual maximum power output in watt (Pmax) on a bicycle ergometer after 6 months of controlled or unobserved physical activity.
Outcome Time Frame:
after 6 months
Safety Issue:
No
Principal Investigator
Richard Greil, Prof.Dr.
Investigator Role:
Study Director
Investigator Affiliation:
Arbeitsgemeinschaft medikamentoese Tumortherapie
Authority:
Austria: Ethikkommission
Study ID:
AGMT_BC_Sports
NCT ID:
NCT01384838
Start Date:
June 2011
Completion Date:
April 2014
Related Keywords:
- Physical Activity
- breast cancer
- physical activity
- sports
- exercise
- Breast Neoplasms